Christoph Rader
Chief Technology Officer, Aethon Therapeutics | Antibody Discovery, Engineering & Conjugation Technologies | Company Creation
- Role
- Chief Technology Officer at Aethon Therapeutics
- Location
- New York, NY, US
- LinkedIn followers
- 500 followers
About Christoph Rader
Biotech scientist & executive driving innovation in biologics and bioconjugates from bench to bedside. Backed by a deep portfolio of patents and publications, I build and lead lean, high-performing, cross-disciplinary teams that pioneer antibody drug and target discovery technologies.
Experience
Chief Technology Officer
Mar 2023 — Present · New York, NY, US
TCEs targeting synthetic neoantigens
Education
University of Zurich
Doctor of Philosophy - PhD, Biochemistry and Molecular Biology
1991 — 1995
University of Bayreuth
Bachelor of Science - BS, Biochemistry
1986 — 1988
University of Zurich
Master of Science - MS, Biochemistry and Molecular Biology
1988 — 1991
Scripps Research
Postdoc, Antibody Engineering
1996 — 1999
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.